Australia's most trusted
source of pharma news
Wednesday, 12 November 2025
Posted 11 November 2025 PM
Roche is the Big Pharma with the best corporate reputation among neurology patient groups, according to the latest PatientView survey.
However, the reputation of the industry as a whole is falling - down nine per cent since 2022 - with neurology patient groups particularly concerned about pricing.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.